Source: Mégarbane, B., Oberlin, M., Alvarez, JC. et al. Management of pharmaceutical and recreational drug poisoning. Ann. Intensive Care 10, 157 (2020). https://doi.org/10.1186/s13613-020-00762-9 Abstract Background Poisoning is one of the leading causes of admission to the emergency department and...
Source: dela Cruz, A.M., Walker, R., Pipes, R. et al. Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care. Addict Sci Clin Pract 16, 12 (2021). https://doi.org/10.1186/s13722-021-00222-0 Abstract Background The treatment...
Presenters: Teresa F. Simmons, LCSW-C Director, Center for Healthy Communities Adjunct Faculty College of Health and Human Services Salisbury University Amy D. Habeger, PhD, MSW, LCSW Associate Professor Department of Social Work Delaware State University
The impact of COVID on the treatment of opioid use disorder in the US Moderator: David A. Fiellin, MD Panelists: Dr. Jose Szapocznik, Paul Joudrey, MD, MPH, Coralee Pérez Pedrogo, PhD
Source: Puckett, H.M., Bossaller, J.S. & Sheets, L.R. The impact of project ECHO on physician preparedness to treat opioid use disorder: a systematic review. Addict Sci Clin Pract 16, 6 (2021). https://doi.org/10.1186/s13722-021-00215-z Abstract Opioid use disorder (OUD) is a medical condition that...
Opioid misuse in increasing in the United States during the COVID-19 outbreak. Coalitions are a vital part of community efforts to prevent opioid misuse. Coalitions should continue to focus on prevention while seeking partnerships with health care and behavioral health agencies. During this second...
Fuente: Fleiz-Bautista, C., Domínguez-García, M., Villatoro-Velázquez, JA., Vázquez-Quiroz, F., Zafra-Mora, E., Sánchez-Ramos R., Resendiz-Escobar E., Bustos-Gamiño M., Medina-Mora ME. Cuqueando la Chiva: Contextos del consumo de heroína en la frontera norte de México… Ciudad de México, México...
Drug overdose deaths are at epidemic levels in the United States. As communities work to combat this complex issue, coalitions are often expected to lead the way. This issue can take coalitions into areas beyond prevention, to address harm reduction, overdose prevention, naloxone distribution and...
Ballreich J, Mansour O, Hu E, et al. Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US. JAMA Netw Open. 2020;3(11):e2023677. doi:10.1001/jamanetworkopen.2020.23677
A decision analytic dynamic Markov model on the US population aged 12 years or older was used to project the number of fatal overdoses caused by any opioid between 2020 – 2029 and project the number of deaths that can be averted by prescribing restrictions, naloxone distribution, and expansion of MAT interventions. Based on data taken from 2010-2018 National Survey on Drug Use and Health, Centers for Disease Control and Prevention, National Health and Nutrition Examination Survey, the US Census, and the National Epidemiologic Survey on Alcohol and Related Conditions- III, the status quo, the...
Virtual Summit 2020
Date: 24th and 25th September 2020
The Improving Outcomes in the Treatment of Opioid Dependence (IOTOD) team are delighted to announce that IOTOD 2020 is going virtual. In light of ongoing restrictions to travel and...
Shared by James Harvey
(ISSUP staff) - 19 يونيو 2020
Event Date
Location:
Tampa
الولايات المتحدة الأمريكية
ICUDDR invites you to join this twitter chat on Opioid Use Disorder and Nutrition with expert panellists Khary Rigg, Ph.D. and Melody Chavez, MPH, RDN, LDN
New resource on how to help prevent an opioid related death. Learn about an overdose including the symptoms, how to respond, information on naloxone, tips on preventing an overdose, and resources for seeking help. Download and share now.
We are witnessing, arguably, the greatest public health issue of our time. However, that is not to say the public health concerns that were present before the pandemic have disappeared.
Opioid addiction and opioid-related deaths continue to cause great harm to society.
This article discusses the way these two critical issues are interacting and causing damage to particularly vulnerable groups of people.
The author describes how social determinants- the conditions in which people are born, grow, live, work and age- influence levels of risk and overall wellbeing.
A recent study, published by the National Drug Research Institute (NDRI) at Curtin University in Perth, has estimated that the illegal use of heroin and the misuse of pharmaceutical opioids is costing Australia around $15.7 billion and causing more than 2200 deaths a year.
This is a significant increase from the previous record that was collected in 2007.
Professor Steve Allsop commented:
“Extra-medical use of opioids is likely to result in adverse outcomes that require the use of health services, reduce work productivity, or result in contact with the criminal justice system,”.
The goal of treatment for opioid addiction or opioid use disorder (OUD) is remission of the disorder leading to lasting recovery.
Recovery is a process of change through which individuals improve their health and wellness, live self-directed lives, and strive to reach their full potential.
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.